按规格使用和贮存,不会发生分解,避免与氧化物接触。
生物活性 Auraptene(7-geranyloxycoumarin)是一种源自柑橘类植物的天然香豆素,具有重要的药理特性,包括抗癌、抗炎、抗幽门螺杆菌、抗氧化和神经保护作用。Auraptene 可抑制 matrix metalloproteinase 2 (MMP-2) 以及关键的炎症介质,如 IL-6、IL-8 和 chemokine (C-C motif) ligand-5(CCL5)。
靶点
化学性质 Auraptene 可溶于甲醇、乙醇和 DMSO 等有机溶剂。它来源于芸香科植物化州柚或柚的未成熟或近成熟的干燥外层果皮,以及柑橘红。
用途 橙皮油内酯具有抗炎和止咳化痰的作用。
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
7-羟基香豆素 | 7-hydroxy-2H-chromen-2-one | 93-35-6 | C9H6O3 | 162.145 |
—— | (R)-6',7'-marmin decanal acetal | 1181223-78-8 | C29H42O5 | 470.649 |
—— | (R)-6-O-(4-geranyloxy-2-hydroxy)cinnamoylmarmin | 142628-36-2 | C38H46O8 | 630.778 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | auraptenol | 108354-46-7 | C19H22O4 | 314.381 |
—— | 7-<3,7-dimethyl-8-oxo-(2E,6E)-2,6-octadienyloxy>coumarin | 30825-46-8 | C19H20O4 | 312.365 |
4-己烯醛,4-甲基-6-[(2-羰基-2H-1-苯并吡喃-7-基)氧代]-,(4E)- | (E)-4-methyl-6-(-coumarin-7'-yloxy)hex-4-enal | 15334-19-7 | C16H16O4 | 272.301 |
—— | 7-((6R)-hydroxy-3,7-dimethyl-2E,7-octadienyloxy)coumarin | 118584-19-3 | C19H22O4 | 314.381 |
—— | 7-(6RS-hydroxy-3,7-dimethyl-2E,7-octadienyloxy)coumarin | 882853-97-6 | C19H22O4 | 314.381 |
—— | 7-<3,7-dimethyl-6-oxo-(2E)-2-octenyloxy>coumarin | 31947-02-1 | C19H22O4 | 314.381 |
Marmin; 7-[[(2E,6R)-6,7-二羟基-3,7-二甲基-2-辛烯-1-基]氧基]-2H-1-苯并吡喃-2-酮 | (6'R,2'E)-dihydroxy-6',7' dimethyl-3',7' octene-2' oxy-7 coumarine | 14957-38-1 | C19H24O5 | 332.397 |
—— | (-)-S-trans-marmin | 61347-54-4 | C19H24O5 | 332.397 |
—— | (+/-)-marmin | 130548-21-9 | C19H24O5 | 332.397 |
—— | 7-(6'-oxo-7'-hydroxy-3',7'-dimethyl-2'-octenyloxy)coumarin | 36413-96-4 | C19H22O5 | 330.381 |
—— | Epoxyaurapten | 21499-17-2 | C19H22O4 | 314.381 |
6',7'-环氧-7-香叶基氧基香豆素 | (E)-7-<<5-(3,3-dimethyloxiranyl)-3-methyl-2-pentenyl>oxy>-2H-1-benzopyran-2-one | 36414-00-3 | C19H22O4 | 314.381 |
—— | (-)-(6'S,2'E)-epoxy-6',7' dimethyl-3',7' octene-2' oxy-7 coumarine | 118628-99-2 | C19H22O4 | 314.381 |
7-羟基香豆素 | 7-hydroxy-2H-chromen-2-one | 93-35-6 | C9H6O3 | 162.145 |
—— | 7-[(2E,6E)-7-(5,5-dimethyl-4-oxooxolan-2-yl)-3-methylocta-2,6-dienoxy]chromen-2-one | 139871-02-6 | C24H28O5 | 396.483 |
—— | (+/-)-(E)-7-<<(3-tetrahydro-5,5-dimethyl-4-oxo-2-furanyl)-2-butenyl>-oxy>-2H-1-benzopyran-2-one | 98066-12-7 | C19H20O5 | 328.365 |
—— | 7-[(2E,6E)-7-(5,5-dimethyl-4-oxofuran-2-yl)-3-methylocta-2,6-dienoxy]chromen-2-one | 139871-00-4 | C24H26O5 | 394.467 |
—— | 7-[[3-[2-(3,3-Dimethyloxiran-2-yl)ethyl]-3-methyloxiran-2-yl]methoxy]chromen-2-one | 115028-76-7 | C19H22O5 | 330.381 |
7-[[(2E)-3-(4,5-二氢-5,5-二甲基-4-氧代-2-呋喃基)-2-丁烯-1-基]氧基]-2H-1-苯并吡喃-2-酮 | geiparvarin | 36413-91-9 | C19H18O5 | 326.349 |
Coumarins possess a wide array of therapeutic capabilities, but often with unclear mechanism of action. We tested a small library of 18 coumarin derivatives against human invasive breast ductal carcinoma cells with the capacity of each compound to inhibit cell proliferation scored, and the most potent coumarin analogues selected for further studies. Interestingly, the presence of two prenyloxy groups (5,7-diprenyloxy-4-methyl-coumarin,